Bacteriophage Injection: The Virus That Works Like a Syringe

The anatomy of a molecular syringe

Under an electron microscope a T4 bacteriophage looks less like a germ than like a lunar lander. It belongs to the tailed phages (Caudoviricetes), and specifically to the contractile-tailed group whose members carry a working piston. Its parts, from top to bottom, are:

• The head, or capsid. A prolate (elongated) icosahedron about 90 nm wide and 120 nm long, built mostly from ~930 copies of the major coat protein gp23, decorated on the outside by the accessory proteins Hoc and Soc. Inside, its ~172 kbp double-stranded DNA genome is packed so tightly — near 500 mg/mL, close to crystalline density — that it sits under an internal pressure of tens of atmospheres.
• The neck and whiskers. A connector (portal) and collar join head to tail; fine fibers called whiskers (fibritin) sense the environment and help deploy the tail fibers.
• The contractile tail. This is the syringe. A rigid inner tube (protein gp19) runs down the center; around it a helical sheath (~138 copies of gp18, in about 23 stacked rings) is cocked like a compressed spring.
• The baseplate and fibers. A hexagonal baseplate caps the tail, carrying a central cell-puncturing spike and radiating long tail fibers (tipped by gp37) plus short tail fibers (gp12). These are the landing gear and the trigger.

Touchdown: adsorption and receptor binding

Infection begins with a search. The six long tail fibers flex and probe until their tips recognize specific molecules on the E. coli surface — for T4, regions of the lipopolysaccharide (LPS) and the outer-membrane porin OmpC. This first binding is reversible: the phage can let go and try again, so it effectively walks across the cell hunting for a committed grip.

Once about three or more long fibers are anchored, the baseplate is pulled close to the membrane and the short tail fibers unfold from beneath it and bind the LPS core irreversibly. This is the point of no return. Receptor specificity here is exactly why phages are so exquisitely host-specific — a phage that fits E. coli OmpC cannot dock on a Staphylococcus, which is both a limitation and, for medicine, a feature: a phage can kill one pathogen and leave the rest of a microbiome untouched.

The trigger: a baseplate that turns inside out

The genius of the machine is that binding and firing are mechanically coupled. When the short fibers lock onto the membrane, they wrench the baseplate through a dramatic conformational change: the hexagonal plate flips from a compact, dome-shaped high-energy state into a splayed, six-pointed star-shaped low-energy state, widening by roughly 15 nm in the process.

That rearrangement is the safety catch releasing. The baseplate is the anchor for the bottom of the sheath, and its expansion no longer holds the sheath subunits in their strained, metastable arrangement. In a heartbeat the entire spring is free to relax — the reason a phage cannot fire until it has genuinely found a host, and the reason it fires all at once. Signal detection at the fibers is transmitted mechanically down the whole assembly, a chain reaction from tip to sheath.

The spring uncoils: tail-sheath contraction

Now the syringe drives home. Each of the ~23 rings of sheath protein snaps from its extended, high-energy geometry into a shorter, fatter, lower-energy one. The sheath contracts to roughly half its original length (from about 92 nm to ~37 nm) while its diameter widens, and because the rigid inner tube is fixed to the sheath's top, the collapsing sheath rams that tube downward and out of the base, straight through the cell envelope.

The physics is elegant: no motor, no fuel, no ATP is spent at the moment of firing. The energy was pre-loaded during assembly, stored as elastic strain in the cocked sheath, and contraction simply lets the structure fall to its ground state — a purely mechanical, spring-loaded stroke. The tip of the tube carries a hardened cell-puncturing device (a gp5–gp27 complex with a needle-sharp β-helix) that pierces the outer membrane, and gp5 also carries a lysozyme domain that locally digests the peptidoglycan wall, clearing a path for the tube. This same contractile mechanism is echoed elsewhere in biology — R-type pyocins and the bacterial Type VI secretion system are evolutionary cousins that fire nearly identical spears.

Threading the genome into the cytoplasm

With the tube spanning the wall, the inner membrane is breached and the phage's genome pours through the hollow channel into the cytoplasm — all ~169–172 thousand base pairs of it, in a matter of seconds. The DNA travels essentially single-file down a channel only a few nanometers wide.

What drives it? The initial thrust comes from the enormous internal capsid pressure — the same tens of atmospheres created when the powerful gp17 terminase motor crammed the genome in during assembly (one of the strongest molecular motors known, generating up to ~60 piconewtons). Ejection is that packaging run in reverse. But pressure alone fades as the head empties, so the trailing genome is thought to be helped across by host processes — molecular crowding and, in a ratchet mechanism best characterized in phages like T7, host RNA polymerase and DNA-binding proteins that can grab the leading end and reel it in as transcription of the earliest phage genes begins. Crucially, the capsid never enters: the empty head and spent tail — a "ghost" — remain stuck to the outside. That fact was the whole point of the famous 1952 Hershey–Chase experiment, which used radioactive labels to show that phage DNA (³²P) goes in while phage protein (³⁵S) stays out, helping prove that DNA, not protein, is the genetic material.

After the injection: hijack, lysis, or the long sleep

The moment the DNA lands, the cell stops being an E. coli and becomes a phage factory. T4 runs a strictly lytic cycle: within minutes it chemically degrades the host chromosome, commandeers the host's ribosomes and polymerases, and pours the cell's resources into making new capsids, tails, and copies of its genome. Roughly 25–30 minutes later, a programmed demolition crew — a holin that punctures the inner membrane, an endolysin that dissolves the peptidoglycan, and spanins that rupture the outer membrane — bursts the cell open, releasing ~100–200 progeny phages to find fresh hosts.

Not every phage kills so quickly. Temperate phages such as lambda offer a second option, the lysogenic cycle: the injected DNA is silenced by a repressor and either integrates into the host chromosome as a dormant prophage (via a site-specific integrase) or is carried as a plasmid, copied passively every time the bacterium divides. It can lie hidden for thousands of generations until stress — DNA damage, the SOS response — cleaves the repressor and flips the switch back to lytic, and the phage escapes a sinking ship. (T4 itself never does this; it is a virulent, always-lytic phage.) Lysogeny is also how phages move bacterial genes around — a temperate phage can carry away host DNA, including, notoriously, the toxin genes that make Corynebacterium diphtheriae and cholera-causing Vibrio deadly.

Why it matters — and how it differs from a flu virus

Phage injection is not a curiosity; it is a keystone of the biosphere and a workhorse of the lab. Phages are the most abundant biological entities on the planet — roughly 10³¹ of them — and by lysing bacteria they turn over a huge fraction of the ocean's biomass and carbon every day. Because they are such precise bacterial killers, they are the basis of phage therapy: using natural or engineered phages to treat antibiotic-resistant infections, an approach pioneered by Félix d'Hérelle a century ago, kept alive at Georgia's Eliava Institute, and now surging back as multidrug resistance spreads. Phages have also built modern molecular biology — T4 DNA ligase, T7 RNA polymerase, lambda cloning vectors, and phage display (a Nobel-winning tool) are all phage parts, and the anti-phage defenses of bacteria gave us both restriction enzymes and CRISPR.

Finally, injection is what sets phages apart from the viruses that infect us. An enveloped animal virus — influenza, HIV, SARS-CoV-2 — is wrapped in a lipid membrane and gets in by fusing that membrane with the host cell's, delivering its entire nucleocapsid (protein shell, genome, and enzymes) into the cytoplasm. A tailed phage does the opposite: it cannot fuse, because bacteria are armored in a rigid cell wall, so it must drill through and inject essentially only its nucleic acid, leaving the shell behind. One virus melts into the cell; the other stands on the outside and fires. That single mechanical difference — fusion versus injection — is dictated by the simplest of facts: animal cells have no wall to punch through, and bacteria do.

The two fates of an injected phage genome: lytic versus lysogenic cycles

Feature	Lytic cycle	Lysogenic cycle
Phage type	Virulent (e.g. T4)	Temperate (e.g. lambda)
Fate of injected DNA	Immediately replicated & expressed	Integrated as a prophage or kept as a plasmid
Host survival	Killed by lysis, ~25–30 min	Survives and divides normally
Genome copying	Many phage genomes per cell	Copied passively with the host chromosome
Output	~100–200 new phages, then burst	No phages until induction (e.g. DNA damage / SOS)
Switch	Default for virulent phages	Repressor (cI) holds it; induction flips to lytic